APOE and nervous system disorder: APOE risk allele frequency for patients and controls was comparable to published series (Murrell et al., 2006; Sando et al., 2008; Lumsden et al., 2020; Figure 1—figure supplement 1A), and analysis of germline mutations did not identify deleterious variants in the 140 genes associated with neurological diseases.